Diabetes Mellitus and Tuberculosis

Bo Kyung Koo

doi:10.4093/dmj.2013.37.4.249

Articles

Page Path: HOME > Diabetes Metab J > Volume 37(4); 2013 > Article

Editorial Epidemiology Diabetes Mellitus and Tuberculosis: Bo Kyung Koo; Diabetes & Metabolism Journal 2013;37(4):249-251.
DOI: https://doi.org/10.4093/dmj.2013.37.4.249
Published online: August 14, 2013

4,845 Views
33 Download
5 Crossref
5 Scopus

Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

Corresponding author: Bo Kyung Koo. Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 156-707, Korea. bokyungkoomd@gmail.com

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next

Full Article

Download PDF

NOTES
REFERENCES
About this article

India experiences a rapidly increasing prevalence of both diabetes mellitus [1] and tuberculosis [2]. Jali et al. [3] showed that nearly half of the patients infected with tuberculosis had either diabetes or were at prediabetic status, which corresponded to previous report in India [4]. Furthermore, among patients with tuberculosis, 16% to 20% were of newly diagnosed cases of diabetes [3,5], which is a strikingly high prevalence of diabetes considering that of general population in India [1].

The association between diabetes and tuberculosis has been well documented in other epidemiologic studies. In Korea, a 3-year longitudinal study showed that the risk ratio of tuberculosis in diabetic patients compared to non-diabetic controls was 3.47 (95% confidential interval, 2.98 to 4.03) [6]. A recent meta-analysis showed that diabetes increased the risk of tuberculosis infection regardless of background tuberculosis incidence or geographic region: people with diabetes have an approximately 3-fold risk of developing active tuberculosis [7].

Although the direct mechanism has not yet been clearly identified, reduced immunity in diabetic patients might play a major role in increase the risk of tuberculosis in them: people with diabetes had reduced chemotaxis and oxidative killing potential than those of nondiabetic control [8]. Studies in animal models showed that diabetic mice infected with Mycobacterium tuberculosis have higher bacterial load [9,10] and reduced T cell response against M. tuberculosis antigen [10] compared to euglycemic mice. Hyperglycemia is associated with a lower production of interferon-γ (IFN-γ) and interleukin-12 [10], and the level of IFN-γ is negatively correlated with levels of glycated hemoglobin (HbA1c) [11].

The levels of hyperglycemia are correlated with the severity of tuberculosis infection quantitatively: the level of IFN-γ is negatively correlated with the levels of HbA1c [11], and poorly controlled diabetes augments the severity of infections [12]. Diabetic patients had more symptoms associated with tuberculosis infection than normal control on presentation [13]. Furthermore, diabetes is associated with poor prognosis of tuberculosis infection: early microscopic negative conversion rate in diabetic patients was lower than that in normal control [13]. Treatment failure rate of 6-month's medication in diabetic patients was also significantly higher than that in normal control [13]. Considering the effect of diabetes on tuberculosis, optimal glycemic control might improve the prognosis of tuberculosis, although there has been few randomized clinical trial to elucidate the effect of glycemic control for tuberculosis.

Whereas a high incidence of tuberculosis has been reported in diabetic patients, it is not clear whether tuberculosis increases the risk of diabetes. In general, infections, including tuberculosis, often worsen hyperglycemia [12]. Tuberculosis infection can stimulate free fatty acid synthesis and secretion [14], which mediates insulin resistance by elevating proinflammatory cytokines, specifically tumor necrosis factor-α [15]. Some studies suggest that tuberculosis can cause diabetes, even in those not previously known to have diabetes [16,17]. However, it is unclear whether diabetes mellitus persists in these patients or whether diabetes is more prevalent with tuberculosis than with other infectious diseases.

Considering the association of tuberculosis and diabetes, screening for tuberculosis in those with diabetes should be considered, especially in the region with high tuberculosis incidence. A systematic review of literature demonstrated that screening of diabetic patients yielded active tuberculosis with rates ranging from 1.7% to 36% [18]. Jali et al. [3] showed that among 4,118 patients with diabetes, 111 subjects (2.7%) had tuberculosis, which was a somewhat low rate considering the high prevalence of tuberculosis in India. They used respiratory symptoms as a screening tool for tuberculosis [3]. Although basic diagnostic approaches such as tuberculosis symptom screening are always applicable, the diagnostic yield is very limited [19]. Considering that India has high prevalence of tuberculosis and that the risk of tuberculosis is higher in patients with diabetes compared to general population, more extensive diagnostic methods such as X-ray screening for the entire group might be applied for patients with diabetes in India.

The burden of tuberculosis in Korea is also high along with India and China: in 2011, 44,684 new cases were reported in South Korea [2], and the proportion of multidrug resistant tuberculosis is increasing in Asian countries [2]. Furthermore, the prevalence of diabetes has reached 10% in the Korean population [20]. Considering the high burden of tuberculosis and diabetes in Korea, screening strategy for tuberculosis in the patients with diabetes reflecting the prevalence of tuberculosis in Korea and studies to elucidate the optimal management of hyperglycemia during active tuberculosis are warranted.

NOTES

No potential conflict of interest relevant to this article was reported.

REFERENCES

1. Ramachandran A, Snehalatha C, Vijay V. Temporal changes in prevalence of type 2 diabetes and impaired glucose tolerance in urban southern India. Diabetes Res Clin Pract 2002;58:55-60. Article PubMed
2. World Health Organization. Global tuberculosis report 2012 cited 2013 Jun 20. Available from: http://www.who.int/tb/publications/global_report/en/.
3. Jali MV, Mahishale VK, Hiremath MB. Bidirectional screening of tuberculosis patients for diabetes mellitus and diabetes patients for tuberculosis. Diabetes Metab J 2013;37:291-295.Article PubMed PMC
4. Viswanathan V, Kumpatla S, Aravindalochanan V, Rajan R, Chinnasamy C, Srinivasan R, Selvam JM, Kapur A. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One 2012;7:e41367Article PubMed PMC
5. Balakrishnan S, Vijayan S, Nair S, Subramoniapillai J, Mrithyunjayan S, Wilson N, Satyanarayana S, Dewan PK, Kumar AM, Karthickeyan D, Willis M, Harries AD, Nair SA. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One 2012;7:e46502Article PubMed PMC
6. Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995;76:529-533. Article PubMed
7. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008;5:e152Article PubMed PMC
8. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med 1982;72:439-450. Article PubMed
9. Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K, Saito A. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 2005;139:57-64. Article PubMed PMC PDF
10. Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H. Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol 2007;37:518-524. Article PubMed PMC
11. Tsukaguchi K, Okamura H, Ikuno M, Kobayashi A, Fukuoka A, Takenaka H, Yamamoto C, Tokuyama T, Okamoto Y, Fu A, Yoshikawa M, Yoneda T, Narita N. The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis. Kekkaku 1997;72:617-622. PubMed
12. Wolf G. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutr Rev 2007;65:251-256. Article PubMed
13. Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, Nelwan RH, Parwati I, van der Meer JW, van Crevel R. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007;45:428-435. Article PubMed
14. Podell BK, Ackart DF, Kirk NM, Eck SP, Bell C, Basaraba RJ. Non-diabetic hyperglycemia exacerbates disease severity in Mycobacterium tuberculosis infected guinea pigs. PLoS ONE 2012;7:e46824Article PubMed PMC
15. Borst SE. The role of TNF-alpha in insulin resistance. Endocrine 2004;23:177-182. PubMed
16. Nichols GP. Diabetes among young tuberculous patients: a review of the association of the two diseases. Am Rev Tuberc 1957;76:1016-1030. PubMed
17. Alisjahbana B, van Crevel R, Sahiratmadja E, den Heijer M, Maya A, Istriana E, Danusantoso H, Ottenhoff TH, Nelwan RH, van der Meer JW. Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 2006;10:696-700. PubMed
18. Jeon CY, Harries AD, Baker MA, Hart JE, Kapur A, Lonnroth K, Ottmani SE, Goonesekera S, Murray MB. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health 2010;15:1300-1314. Article PubMed
19. Nishikiori N, Van Weezenbeek C. Target prioritization and strategy selection for active case-finding of pulmonary tuberculosis: a tool to support country-level project planning. BMC Public Health 2013;13:97Article PubMed PMC PDF
20. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011;35:303-308. Article PubMed PMC

Figure & Data

References

Citations

Citations to this article as recorded by

Magnitude of opportunistic infections and associated factors among adult people living with human immune deficient virus on art at selected public hospital, mogadishu somalia: cross-sectional study
Abdirahman Khalif Mohamud, Omar Abdullahi Ahmed, Abdulrahman Ahmed Mohamud, Najib Isse Dirie
Annals of Medicine & Surgery.2023; 85(7): 3364. CrossRef
Diabetes mellitus: an important risk factor for reactivation of tuberculosis
Ernesto Solá, Carmen Rivera, Michelle Mangual, José Martinez, Kelvin Rivera, Ricardo Fernandez
Endocrinology, Diabetes & Metabolism Case Reports.2016;[Epub] CrossRef
A Spatial, Social and Environmental Study of Tuberculosis in China Using Statistical and GIS Technology
Wenyi Sun, Jianhua Gong, Jieping Zhou, Yanlin Zhao, Junxiang Tan, Abdoul Ibrahim, Yang Zhou
International Journal of Environmental Research and Public Health.2015; 12(2): 1425. CrossRef
Achievements in and Challenges of Tuberculosis Control in South Korea
Ji Han Kim, Jae-Joon Yim
Emerging Infectious Diseases.2015; 21(11): 1913. CrossRef
Exploration of ecological factors related to the spatial heterogeneity of tuberculosis prevalence in P. R. China
Xin-Xu Li, Li-Xia Wang, Juan Zhang, Yun-Xia Liu, Hui Zhang, Shi-Wen Jiang, Jia-Xu Chen, Xiao-Nong Zhou
Global Health Action.2014;[Epub] CrossRef

PubReader

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format: